Clinical trial
Deciphering the Self-antigen Specific T Cell Signature of Autoimmune Liver Diseases
NCT07784881 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Deciphering the Self-antigen Specific T Cell Signature of Autoimmune Liver Diseases
- Lead sponsor
- Nantes University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 20, 2021
- Completion date
- October 24, 2025
- Enrollment
- 220 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autoimmune hepatitis, autoimmune liver disease, primary biliary cholangitis (pbc), primary sclerosing cholangitis (psc)